Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
2.100
+0.150 (7.69%)
At close: Jan 22, 2026, 4:00 PM EST
2.120
+0.020 (0.95%)
After-hours: Jan 22, 2026, 7:42 PM EST
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $356.87 million as of January 22, 2026. Its market cap has decreased by -10.93% in one year.
Market Cap
356.87M
Enterprise Value
205.43M
1-Year Change
-10.93%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $356.87M, a decrease of -86.18%. That is a compound annual growth rate of -56.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 356.87M | 17.32% |
| Dec 31, 2025 | 304.19M | -82.24% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foghorn Therapeutics | 346.22M |
| Zura Bio | 340.07M |
| XOMA Royalty | 334.59M |
| Puma Biotechnology | 333.09M |
| Aardvark Therapeutics | 332.48M |
| Aura Biosciences | 331.49M |
| Candel Therapeutics | 329.39M |
| AC Immune | 328.49M |